SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020

Jesse Fryk; Hazel Clothier; Stacey L Rowe; Georgina Lewis; Emma Roney; Nigel Crawford; Jim Buttery

doi:10.33321/cdi.2026.50.012

February 23, 2026Communicable Diseases IntelligenceOpen Access

SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess and report on the safety of vaccines administered in Victoria through AEFI surveillance.
Utilized the SAEFVIC model for adverse event monitoring.
Collected data on vaccine-related adverse events from 2019 to 2020.
Established a baseline for comparison with the COVID-19 vaccination program.
Confirmed robust AEFI monitoring in Victoria.
Provided foundational data for assessing future vaccine safety programs.

Implication

Surveillance reports safety of vaccines in Victoria, indicating strong confidence for future comparisons.

Abstract

AEFI surveillance in Victoria continues to be robust through the SAEFVIC model and provides confidence in informing the safety profile of vaccines administered in Australia. These data provide a baseline for AEFI surveillance for comparison to the COVID-19 vaccination program commenced in 2021.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fryk et al. (2026) studied this question.

synapsesocial.com/papers/699fe24b95ddcd3a253e6313 https://doi.org/10.33321/cdi.2026.50.012

View Full Paper

Ask AI

Bookmark

Share

SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020

Key Points

Implication

Abstract

Discussion

Cite This Study

SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading